Di Nuzzo Private Wealth, Inc. Exact Sciences Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $634 Million
- Q3 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 14 shares of EXAS stock, worth $831. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$831
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
673Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.06 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$941 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$851 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$717 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$397 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.5B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...